Pharmacokinetics of 19-nortestosterone esters in normal men

https://doi.org/10.1016/0022-4731(85)90215-8Get rights and content

Abstract

A reliable method for the isolation of 19-nortestosterone (NT), testosterone (T) and dihydrotestosterone (DHT) by high-performance liquid chromatography (HPLC) and quantitation of the individual steroids by radioimmunoassays is described. The method was used to measure serum concentrations of NT, T and DHT in a pharmacokinetic study and in a clinical trial for male fertility control. Following intramuscular injection of either 50 mg 19-nortestosterone-3-(p-hexoxyphenyl)-propionate (NP) or 50 mg 19-nortestosterone-decanoate (ND) serum NT increased rapidly to maximal concentrations of 4.6 ± 3.2 and 2.0 ± 1.3 nmol/l (±SD), respectively, in the 6 volunteers. The half-life time was 8 days for ND and 21 days for NP. Based on these findings a clinical trial with NP was performed. NP was given to 5 healthy men in doses of 10mg/week for the first 3 weeks followed by 200 mg/week for 10 further weeks. Serum NT levels increased gradually and maximal concentrations were reached in the 13th treatment week (20.2 ± 3.4nmol/l). Measurable amounts of NT were detectable for 19 weeks after the last injection. The study shows that NT accumulates under this treatment regime and wider spacing of the injection intervals may be possible in future trials.

References (27)

  • T. Schürmeyer et al.

    Reversible azoospermia induced by the anabolic steroid 19-nortestosterone

    Lancet

    (1984)
  • W.R. Jondorf et al.

    Application of RIA method for detecting nandrolone in equine and canine plasma

    Vet. Res.

    (1977)
  • R. Dugal et al.

    Radioimmuno-assay of anabolic steroids: An evaluation of three antisera for the detection of anabolic steroids in biological fluids

    Schweiz. Z. Sportmed.

    (1979)
  • R. Hampl et al.

    Radio-immunoassay of nortestosterone and related steroids

    J. clin. Chem. clin. Biochem.

    (1979)
  • R.V. Brooks et al.

    Detection of anabolic steroid administration to athletes

    J. steroid Biochem.

    (1979)
  • A. Bosch

    A radio-immunoassay of 19-nortestosterone using celite column chromatography

    J. clin. Chem. clin. Biochem.

    (1984)
  • E.H.J.M. Jansen et al.

    Development of a chemiluminescent immunoassay for 19-nortestosterone (nandrolon)

    Vet. Q.

    (1984)
  • E.H.J.M Jansen et al.

    Monitoring and identification of residues of anabolic preparations in slaughtered cattle by HPLC with diode array detection

    Vet. Q.

    (1984)
  • E. Houghton et al.

    Studies related to the metabolism of anabolic steroids in the horse: a gas chromatographic-mass spectroscopic method to confirm the administration of 19-nortestosterone or its esters to horse

    Biomed. Mass Spectrom.

    (1978)
  • M. Schöneshöfer et al.

    Assessment of eleven adrenal steroids from a single serum sample by combination of high-performance liquid chromatography and radioimmunoassay (HPLC-RIA)

    J. steroid Biochem.

    (1981)
  • M. Schöneshöfer et al.

    Specific estimation of fifteen unconjugated. non-metabolized steroid hormones in human urine

    J. steroid Biochem.

    (1983)
  • M. Schöneshöfer et al.

    Estimation of free urinary aldosterone and 18-hydroxy-corticosterone by combination of automatic high performance liquid chromatography and radioimunoassay

    J. Chromat.

    (1982)
  • S.J. Cook et al.

    Quantitation of six androgens by combined high performance liquid chromatography and radioimmunoassay

    Steroids

    (1982)
  • Cited by (44)

    • The scaffold protein RACK1 is a target of endocrine disrupting chemicals (EDCs) with important implication in immunity

      2017, Toxicology and Applied Pharmacology
      Citation Excerpt :

      Results obtained confirm that AR agonist/antagonist can modulate RACK1 expression in opposite way, leading to an enhancement or a decrease in the response to classic innate immunity stimuli and modulation of cell proliferation. The concentrations used were relevant to human exposure, as for nandrolone following intramuscular injection of either 50 mg 19-nortestosterone-3-(p-hexoxyphenyl)-propionate or 50 mg 19-nortestosterone-decanoate, serum nandrolone increased rapidly to maximal concentrations of 4.6 ± 3.2 and 2.0 ± 1.3 nM (± SD), respectively (Belkien et al., 1985). While the levels of p,p′DDT and p,p′DDE in the human population are highly variable, in a study conducted in a relatively highly exposed population of farmers in the United States, the median plasma p,p′DDE concentration was 7.7 μg/l equivalent to 24 nM (range, 0.6–77.4 μg/l) (Cooper et al., 2004), while Barraza-Villarreal et al. (2004) reported in Mexican males mean plasma p,p′DDE and p,p′DDT levels of 203.5 μg/l equivalent to 640 nM and 67.4 μg/l equivalent to 21 nM, respectively.

    • Atypical excretion profile and GC/C/IRMS findings may last for nine months after a single dose of nandrolone decanoate

      2016, Steroids
      Citation Excerpt :

      Even though the 19-NT metabolites 19-NA and 19-NE were detected 9 months post dose, the excretion of 19-NT itself was not detectable on day 120 and 270 in any of the subjects. This is in agreement with other studies showing that the half-life of ND is approximately 8–12 days [22,23]. The reason for the longer half-life of the metabolites is not known, but may be due to accumulation in adipose tissues and/or more extensive binding to carrier proteins.

    • The beneficial effects of strength exercise on hippocampal cell proliferation and apoptotic signaling is impaired by anabolic androgenic steroids

      2014, Psychoneuroendocrinology
      Citation Excerpt :

      In general, AAS users are engaged in typical strength exercise to improve their muscle mass by hypertrophy (Hartgens and Kuipers, 2004). Yet, when administered chronically (13 weeks), the serum concentration of ND remains different from basal values until 18 weeks after the last injection (Belkien et al., 1985). In addition, pharmacokinetics studies have shown that the half-life of ND even after a single injection is approximately 5 ± 8 days (5–17 days) (Belkien et al., 1985; Minto et al., 1997; Bagchus et al., 2005).

    • On the association between nandrolone-mediated testosterone reduction during alcohol intoxication and attenuated voluntary alcohol intake in rats

      2013, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      The present testosterone elevations are puzzling since the primary effect of the nandrolone decanoate treatment should be a rather long-lasting feedback inhibition of the testosterone synthesis (Minto et al., 1997). This long-lasting testosterone reduction has been explained by the slow half-life of the release of the ester from the intramuscular depot, approximately 6–8 days in humans (Belkien et al., 1985; Wijnand et al., 1985) and 5 days in rats (van der Vies, 1985). In the present study, we have used subcutaneous nandrolone decanoate injection, which is not known to affect pharmacokinetics in a substantially different way compared with intramuscular administration.

    • Fullerene-C<inf>60</inf>-modified electrode as a sensitive voltammetric sensor for detection of nandrolone-An anabolic steroid used in doping

      2007, Analytica Chimica Acta
      Citation Excerpt :

      The OSWV method was finally selected for the determination of nandrolone since it was able to determine lower concentrations of this substance. When released in the bloodstream, the ester bond of nandrolone decanoate is easily broken yielding the parent drug, nandrolone [3]. Buckminsterfullerene (C60) has attracted much attention of researchers owing to its remarkable electrochemical properties [24].

    View all citing articles on Scopus
    View full text